Tenet Healthcare (NYSE: THC) shares jumped sharply on Friday after the hospital chain posted second-quarter results that significantly exceeded Wall Street expectations.
The stock climbed 16.8% as of midday trading, reflecting strong investor enthusiasm over both the earnings beat and the company’s improved financial outlook for the rest of 2026.
Tenet reported revenue of $5.63 billion for the three months ending in June, well above the analyst consensus estimate of $5.43 billion for the quarter.
Adjusted earnings per share came in at $6.12, a substantial beat compared to analyst expectations of just $4.26 per share for the period.
Both figures represent meaningful year-over-year growth, with revenue up from $5.27 billion and earnings up from $4.02 per share in the same quarter last year.
CEO Saum Sutaria, M.D., said “We are actively navigating current industry dynamics through excellent operational execution, investments in innovation, and a continued focus on higher acuity services to sustain growth, margins and significant free cash flow.”
The strong results are particularly notable given recent industry anxiety sparked by rival HCA Healthcare, which in mid-July dialed back its full-year profit guidance due to a growing number of uninsured patients.
That warning had weighed heavily on hospital sector stocks broadly, making Tenet’s ability to push through those pressures all the more impressive to investors.
Tenet raised its full-year 2026 revenue guidance to a range of $21.9 billion to $22.5 billion, up from a prior estimate of $21.5 billion to $22.3 billion, and ahead of analyst expectations of just under $22.0 billion.
The company also lifted its adjusted EBITDA outlook for fiscal 2026, raising the forecast from a previous range of $4.485 billion to $4.785 billion to an updated range of $4.83 billion to $5.03 billion.
The broad upward revision across multiple financial metrics signals that management is confident the company can sustain momentum despite persistent cost headwinds facing the wider hospital industry.
Analysts were already bullish on Tenet Healthcare before Thursday’s earnings release, with a consensus price target of $246.90, which remains above the stock’s current trading price even after today’s significant rally.
That consensus price target is widely expected to move higher as analysts revise their models to reflect the improved guidance numbers Tenet has now put forward.
However, investors considering entering a position may want to exercise patience, as a gain of this magnitude within a single trading session often invites profit-taking pressure in the days that follow.
Allowing that short-term volatility to run its course could present a more attractive entry point for those taking a longer-term view on the stock.
